Star Combo Pharma Ltd (S66) - Total Liabilities

Latest as of June 2025: AU$10.19 Million AUD ≈ $7.21 Million USD

Based on the latest financial reports, Star Combo Pharma Ltd (S66) has total liabilities worth AU$10.19 Million AUD (≈ $7.21 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Star Combo Pharma Ltd to assess how effectively this company generates cash.

Star Combo Pharma Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Star Combo Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data. Check S66 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Star Combo Pharma Ltd Competitors by Total Liabilities

The table below lists competitors of Star Combo Pharma Ltd ranked by their total liabilities.

Company Country Total Liabilities
Clime Investment Management Ltd
AU:CIW
Australia AU$3.72 Million
Manganese X Energy Corp
V:MN
Canada CA$59.62K
Precio Fishbone AB (publ)
ST:PRCO-B
Sweden Skr55.57 Million
Theta Edge Bhd
KLSE:9075
Malaysia RM114.89 Million
VONEX Ltd
AU:VN8
Australia AU$21.78 Million
Prajay Engineers Syndicate Limited
NSE:PRAENG
India Rs3.31 Billion
High-Tech Metals Ltd
AU:HTM
Australia AU$256.47K
Mexco Energy Corporation
NYSE MKT:MXC
USA $1.02 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Star Combo Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Star Combo Pharma Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.40 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 3.09 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.27 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Star Combo Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Star Combo Pharma Ltd (2016–2025)

The table below shows the annual total liabilities of Star Combo Pharma Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-06-30 AU$10.19 Million
≈ $7.21 Million
+9.50%
2024-06-30 AU$9.30 Million
≈ $6.58 Million
+3.76%
2023-06-30 AU$8.97 Million
≈ $6.35 Million
+11.56%
2022-06-30 AU$8.04 Million
≈ $5.69 Million
+12.75%
2021-06-30 AU$7.13 Million
≈ $5.04 Million
-30.22%
2020-06-30 AU$10.22 Million
≈ $7.23 Million
+36.12%
2019-06-30 AU$7.51 Million
≈ $5.31 Million
+170.36%
2018-06-30 AU$2.78 Million
≈ $1.96 Million
-23.62%
2017-06-30 AU$3.64 Million
≈ $2.57 Million
+13.40%
2016-06-30 AU$3.21 Million
≈ $2.27 Million
--

About Star Combo Pharma Ltd

AU:S66 Australia Household & Personal Products
Market Cap
$18.64 Million
AU$26.34 Million AUD
Market Cap Rank
#25234 Global
#1116 in Australia
Share Price
AU$0.20
Change (1 day)
-13.33%
52-Week Range
AU$0.14 - AU$0.27
All Time High
AU$1.72
About

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more